ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2154

Improvement In Clinical Symptoms After 48 Weeks Of Wearing Flexible Footwear In Osteoarthritis Of Knee: A Randomized Placebo-Controlled Study

Najia Shakoor1, Roy H. Lidtke2, Louis F. Fogg3, Laura E. Thorp4, Markus A. Wimmer5, Rachel A. Mikolaitis2 and Joel A. Block2, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Section of Rheumatology, Rush University Medical Center, Chicago, IL, 3Department of Nursing, Rush University Medical Center, Chicago, IL, 4Anatomy and Cell Biology, Rush University Medical Center, Chicago, IL, 5Orthopedic Surgery, Rush University Medical Center, Chicago, IL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Biomechanics, foot wear, osteoarthritis and pain

  • Tweet
  • Email
  • Print
Session Information

Session Title: Osteoarthritis - Clinical Aspects II: Symptoms and Therapeutics in Osteoarthritis.

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Osteoarthritis (OA), the most common form of arthritis, is a major cause of pain and disability.  Biomechanical interventions that reduce dynamic loading are a promising strategy to improve pain and retard disease progression, though prior studies in OA have not shown dramatic efficacy.  In addition, the large placebo effect inherent in studies of OA pain make it difficult to prove clinical efficacy in short studies. Here, we present data from a double-blind randomized controlled study of a flexible shoe (“mobility” shoe), which has previously been shown to reduce medial compartment knee loading, on self-reported clinical outcomes over 48 weeks.  

Methods:   Participants were enrolled in a 6-month randomized controlled study of a flexible soled shoe (mobility shoe) vs identical appearing control shoe with stiffer sole.  Participants had the opportunity to continue the study for an additional 18 months.  Here, we evaluate the interim 48 week data.  All participants had radiographic (KL grades ≥ 2) and symptomatic (at least 30/100 mm pain on VAS) medial compartment knee OA.  Investigators and participants were blinded to shoe assignment. Baseline and follow up clinical symptoms were evaluated using WOMAC visual analog scales and modified KOOS questionnaires.  Data were evaluated to determine “responders” according to modified OMERACT-OARSI responder criteria, with Chi-squared analysis to evaluate the difference in number of responders.  Independent samples t-test was used to evaluate differences in percent improvement in WOMAC and KOOS subscales between the groups.

Results: 50 participants were enrolled in the randomized controlled trial, 22 to the active “mobility” shoe and 28 to the control group.  24 participants continued with the study extension, 11 in the “mobility” group (7 female, mean age 59±4 years) and 13 in the control group (10 female, mean age 52±9 years).   Changes in pain and symptoms over 48 weeks are detailed in the Table.  Overall, there were greater improvements in pain, function and quality of life measures in the active mobility group vs control group.  Changes in pain were not correlated with age.  In addition, using OMERACT-OARSI response criteria, the mobility group had significantly more responders (10 out of 11) than the control group (6 out of 13), (Chi squared= 5.37, df=1, p=0.023). Thus, participants who wore the flexible shoe were 1.98 times more likely to show clinical improvement than those in the control.

Conclusion:   These data demonstrate significant clinical improvements in the active group, assigned to flexible footwear, compared to a non-flexible footwear control group, including a higher percentage of OMERACT-OARSI responders and greater percent improvements in self-reported clinical outcomes measures in the active group.  Notwithstanding the small numbers, these results suggest optimism for the long term efficacy of biomechanical interventions for knee OA. 

Table

 

Improvement in mobility group  (%±SD)

Improvement in control group (%±SD)

p value for difference between groups

WOMAC pain

73±26

37±57

0.06

WOMAC function

70±40

40±70

0.22

WOMAC stiffness

73±30

41±44

0.05

KOOS symptoms

13±21

4±19

0.05

KOOS pain

39±56

6±35

0.10

KOOS quality of life

42±66

11±37

0.02

KOOS sports and recreation

67±200

29±33

0.55

 


Disclosure:

N. Shakoor,

Dr. Comfort ,

7;

R. H. Lidtke,

Dr. Comfort,

7,

Dr. Comfort,

5;

L. F. Fogg,
None;

L. E. Thorp,
None;

M. A. Wimmer,
None;

R. A. Mikolaitis,
None;

J. A. Block,

Ferring, Inc.,

5,

PL Pharma, Inc.,

9.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improvement-in-clinical-symptoms-after-48-weeks-of-wearing-flexible-footwear-in-osteoarthritis-of-knee-a-randomized-placebo-controlled-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies